37 EUR
0.1
0.27%
Last update Dec 15, 5:30 PM CET
Market closed
Day range
36.80000
37.30000
Previous close
37.099998
Open
37.30000
Access this stock data via API
Subscribe
Dermapharm Holding SE
37.00
0.10
0.27%

Financials

Income statement

Fiscal date Jun 2025 Mar 2025 Dec 2024 Sep 2024
Total reported revenue 272.1M 302.4M 290.7M 311.6M
Cost of revenue 88.0M 103.2M 97.5M 115.2M
Gross profit 184.1M 199.2M 193.2M 196.4M
Operating expense
Research & development
Selling general and admin
Other operating expenses 49.2M 49.3M -75.3M 49.6M
Operating income 44.5M 59.8M 45.7M 66.1M
Non operating interest income
Income 1.3M 2.4M -608K 5.3M
Expense 13.2M 12.9M 11.5M 17.9M
Other income expense
Pretax income 32.5M 49.7M 34.6M 46.8M
Tax provision 11.6M 16.5M 15.5M 14.0M
Net income 20.9M 33.2M 19.0M 32.8M
Basic EPS 0.4 0.6
Diluted EPS 0.4 0.6
Basic average shares 53.6M 53.9M
Diluted average shares 53.6M 53.9M
EBITDA 66.1M 82.5M 72.2M 85.5M
Net income from continuing op. 32.5M 49.7M 34.6M 46.8M
Minority interests 2K 208K 1.5M -376K
Preferred stock dividends 0 0 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in less than a minute

06:59
00:00
09:00
17:45
23:59

Trading Hours (Monday - Friday):

Pre-market
07:00 - 09:00
Main market
09:00 - 17:45
Post-market
17:30 - 20:30
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).